Showing results (181-190 of 1,688) with videos related to
Sort By:
Pageof 169
Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.Breast Cancer Research and Treatment|March 1, 2017
Identification of frequent somatic mutations in inflammatory breast cancerNaoko Matsuda, Bora Lim, Ying Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue SarcomaVivek Subbiah, Christian Meyer, Ralph Zinner, et al.Biomedical Optics Express|January 28, 2014
Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agentsFunda Meric-Bernstam, John C Rasmussen, Savitri Krishnamurthy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcomeChafika Mazouni, Florentia Peintinger, Shu Wan-Kau, et al.Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.International Journal of Medical Informatics|February 17, 2016
Patient knowledge and information-seeking about personalized cancer therapyDeevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, et al.Nature Reviews. Gastroenterology & Hepatology|November 7, 2022
Current developments in gastric cancer: from molecular profiling to treatment strategyMaria Alsina, Virginia Arrazubi, Marc Diez, et al.Recent Patents on Anti-Cancer Drug Discovery|February 8, 2011
Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2Rodrigo Dienstmann, Jordi Rodon, Ben Markman, et al.Nature Reviews. Clinical Oncology|February 13, 2013
Development of PI3K inhibitors: lessons learned from early clinical trialsJordi Rodon, Rodrigo Dienstmann, Violeta Serra, et al.Pageof 169